PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DGX vs. ^SP500TR
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between DGX and ^SP500TR is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

DGX vs. ^SP500TR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quest Diagnostics Incorporated (DGX) and S&P 500 Total Return (^SP500TR). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
4.58%
9.66%
DGX
^SP500TR

Key characteristics

Sharpe Ratio

DGX:

0.77

^SP500TR:

2.20

Sortino Ratio

DGX:

1.35

^SP500TR:

2.91

Omega Ratio

DGX:

1.15

^SP500TR:

1.40

Calmar Ratio

DGX:

0.62

^SP500TR:

3.35

Martin Ratio

DGX:

4.06

^SP500TR:

13.96

Ulcer Index

DGX:

3.80%

^SP500TR:

2.03%

Daily Std Dev

DGX:

19.98%

^SP500TR:

12.88%

Max Drawdown

DGX:

-49.46%

^SP500TR:

-55.25%

Current Drawdown

DGX:

-7.29%

^SP500TR:

-1.40%

Returns By Period

In the year-to-date period, DGX achieves a 0.72% return, which is significantly lower than ^SP500TR's 2.01% return. Over the past 10 years, DGX has underperformed ^SP500TR with an annualized return of 10.38%, while ^SP500TR has yielded a comparatively higher 13.50% annualized return.


DGX

YTD

0.72%

1M

0.28%

6M

4.58%

1Y

16.46%

5Y*

9.48%

10Y*

10.38%

^SP500TR

YTD

2.01%

1M

2.30%

6M

9.66%

1Y

25.61%

5Y*

14.31%

10Y*

13.50%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DGX vs. ^SP500TR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DGX
The Risk-Adjusted Performance Rank of DGX is 7070
Overall Rank
The Sharpe Ratio Rank of DGX is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of DGX is 6868
Sortino Ratio Rank
The Omega Ratio Rank of DGX is 6363
Omega Ratio Rank
The Calmar Ratio Rank of DGX is 7070
Calmar Ratio Rank
The Martin Ratio Rank of DGX is 7777
Martin Ratio Rank

^SP500TR
The Risk-Adjusted Performance Rank of ^SP500TR is 9696
Overall Rank
The Sharpe Ratio Rank of ^SP500TR is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of ^SP500TR is 9494
Sortino Ratio Rank
The Omega Ratio Rank of ^SP500TR is 9797
Omega Ratio Rank
The Calmar Ratio Rank of ^SP500TR is 9696
Calmar Ratio Rank
The Martin Ratio Rank of ^SP500TR is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DGX vs. ^SP500TR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and S&P 500 Total Return (^SP500TR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DGX, currently valued at 0.77, compared to the broader market-2.000.002.004.000.772.20
The chart of Sortino ratio for DGX, currently valued at 1.35, compared to the broader market-4.00-2.000.002.004.001.352.91
The chart of Omega ratio for DGX, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.40
The chart of Calmar ratio for DGX, currently valued at 0.62, compared to the broader market0.002.004.006.000.623.35
The chart of Martin ratio for DGX, currently valued at 4.06, compared to the broader market-10.000.0010.0020.004.0613.96
DGX
^SP500TR

The current DGX Sharpe Ratio is 0.77, which is lower than the ^SP500TR Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of DGX and ^SP500TR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
0.77
2.20
DGX
^SP500TR

Drawdowns

DGX vs. ^SP500TR - Drawdown Comparison

The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum ^SP500TR drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for DGX and ^SP500TR. For additional features, visit the drawdowns tool.


-14.00%-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-7.29%
-1.40%
DGX
^SP500TR

Volatility

DGX vs. ^SP500TR - Volatility Comparison

Quest Diagnostics Incorporated (DGX) and S&P 500 Total Return (^SP500TR) have volatilities of 4.93% and 5.07%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%AugustSeptemberOctoberNovemberDecember2025
4.93%
5.07%
DGX
^SP500TR
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab